Dr. Elizabeth Jaffee

Dr. Elizabeth Jaffee, a prominent leader in cancer immunotherapy and Deputy Director at Johns Hopkins, shares her inspiring journey into battling pancreatic cancer. She discusses how early KRAS mutations can be targeted with vaccines to potentially prevent cancer recurrence. Dr. Jaffee emphasizes the importance of using AI in identifying high-risk patients and integrating it with genetic data for personalized prevention. She also highlights the promising results of neoadjuvant immunotherapy and the role of KRAS inhibitors in overcoming treatment resistance.